Immunization

AstraZeneca’s investigational coronavirus disease 2019 (COVID-19) vaccine candidate, AZD1222, has expanded into a phase 3 clinical trial.

New data show that the percentage of adults over the age of 60 years old who received the shingles vaccine has jumped from 6.7% in 2008 to 34.5% in 2018.

A survey conducted by NCPA polled nearly 800 community pharmacy owners/managers on whether they plan to offer a COVID-19 vaccine in their pharmacies.

Results of a new study on immunization rates and current barriers at Wisconsin pharmacies demonstrated that collaborating with physicians could provide significant benefits to patients.

NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.

ASHP issued its recommended principles for the development, distribution, allocation, and oversight of an eventual COVID-19 vaccine.

Experts caution about safety measures to take when offering parking lot vaccines.

Primary updates to the guidance includes the composition of the 2020-2021 flu vaccines and the recent licensures of 2 new influenza vaccines.

A school flu vaccine program resulted in decreased influenza hospitalizations for all age groups and fewer illness-related school absences, suggesting herd immunity.

Twelve pharmacy organization issued a joint statement in response to the expansion of the pharmacist's role in providing vaccines to children.

Two senior administration officials from Operation Warp Speed offered the latest updates on COVID-19 vaccine development.

HHS authorized all state-licensed pharmacists to order and administer childhood vaccinations amid the coronavirus disease 2019 (COVID-19) pandemic.

Walgreens has announced its commitment to getting ahead of an early and condensed flu season amid the COVID-19 pandemic.

Here's the coronavirus-related news from this week that you should know.

The pharmaceutical company increased production by more than 25% in the United States.

Pharmacists should counsel patients on how taking steps now can prevent certain cancers later.

The US government and Moderna are collaborating to produce 100 million doses of investigational COVID-19 vaccine candidate mRNA-1273.

Keep up-to-date on flu vaccine options and counseling considerations, especially as coronavirus disease 2019 continues to strike.

Experts worry that the approval is prioritizing the economy and national prestige over safety.

Age, gender, race, and general health make the list of potential risk factors for shingles.

The report showed that the vaccination rate has quintupled over the last decade.

Three scientists discuss the global race for a COVID-19 vaccine.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.

In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.